SCHEMBL2813289

SCHEMBL2813289

FC(=C\Sc1ccccc1)/C(=N/c1ccccc1)Sc1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 2/20 0.33
HTR3B O95264 2/20 0.33
HTR3A P46098 2/20 0.33
HTR3D Q70Z44 2/20 0.33
HTR3C Q8WXA8 2/20 0.33
SLC22A2 O15244 1/20 0.33
SLC22A1 O15245 1/20 0.33
SLC22A3 O75751 1/20 0.33
PLAU P00749 1/20 0.33
NOS1 P29475 4/20 0.32
NOS3 P29474 3/20 0.32
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
LMNA P02545 2/20 0.30
PLIN1 O60240 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
HTT P42858 1/20 0.30
PLIN5 Q00G26 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12850794 1.00 HTR3E (0.33) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2813292 1.00 HTR3E (0.33) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL12850795 0.93 SLC22A2 (0.31) SLC22A2SLC22A1SLC22A3PLAUNOS1
SCHEMBL2813467 0.93 SLC22A2 (0.31) SLC22A2SLC22A1SLC22A3PLAUNOS1
SCHEMBL2813470 0.93 SLC22A2 (0.31) SLC22A2SLC22A1SLC22A3PLAUNOS1
SCHEMBL12850793 0.82 HTR3E (0.34) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2808950 0.82 HTR3E (0.34) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2808953 0.82 HTR3E (0.34) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2809204 0.82 NOS1 (0.41) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL12850790 0.82 NOS1 (0.41) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 HTR3E 3827/4885HTR3B 4065/4885HTR3A 2857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.